ADIPOQ and type 2 diabetes mellitus: In addition, we were able to account for potential confounding effects of a wide range of biomarkers presenting different pathways leading to onset of type 2 diabetes (including hs-CRP, adiponectin, GGT, ALT, fetuin-A, HDL-cholesterol and triacylglycerol), some of which were not accounted for in previous studies.